158 related articles for article (PubMed ID: 12759551)
1. Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.
Rossi E; Perrone F; Labonia V; Landi G; Nuzzo F; Amabile G; Gridelli C; Di Maio M; D'Aiuto G; de Matteis A
Oncology; 2003; 64(4):479-80. PubMed ID: 12759551
[No Abstract] [Full Text] [Related]
2. Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study.
Riccardi A; Brugnatelli S; Danova M; Giordano M; Pugliese P; Luchena G; Grasso D; Trotti G; Bertè R; Pansini G; Tinelli C
Tumori; 2006; 92(1):6-12. PubMed ID: 16683377
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
O'Shaughnessy J
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.
Martín M; Ruiz A; Muñoz M; Balil A; García-Mata J; Calvo L; Carrasco E; Mahillo E; Casado A; García-Saenz JA; Escudero MJ; Guillem V; Jara C; Ribelles N; Salas F; Soto C; Morales-Vasquez F; Rodríguez CA; Adrover E; Mel JR;
Lancet Oncol; 2007 Mar; 8(3):219-25. PubMed ID: 17329192
[TBL] [Abstract][Full Text] [Related]
5. Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.
Halim A; Wahba H
Med Oncol; 2012 Jun; 29(2):454-8. PubMed ID: 21350875
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.
Hortobagyi GN
Clin Breast Cancer; 2002 May; 3 Suppl 1():34-8. PubMed ID: 12057044
[TBL] [Abstract][Full Text] [Related]
7. Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast Cancer.
He K; Wang X; Guan X; Yu Q; Ma Q; Liu Z; Yu Z
Anticancer Res; 2017 Oct; 37(10):5647-5653. PubMed ID: 28982882
[TBL] [Abstract][Full Text] [Related]
8. The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.
Morabito A; Filippelli G; Palmeri S; Cascinu S; Ferraù F; Zagonel V; Gattuso D; Catalano V; Capaccetti B; Franciosi V; Accurso V; Scinto F; Gasparini G
Breast Cancer Res Treat; 2003 Mar; 78(1):29-36. PubMed ID: 12611454
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial.
Lobo F; Virizuela JA; Dorta FJ; Florián J; Lomas M; Jiménez E; López P; Casado V; Léon A; Estévez LG; Dómine M;
Clin Breast Cancer; 2003 Apr; 4(1):46-50. PubMed ID: 12744758
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases].
Zhou NN; Teng XY; Jiang WQ; Liu DG
Ai Zheng; 2007 Dec; 26(12):1373-6. PubMed ID: 18076805
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.
Gennatas C; Michalaki V; Mouratidou D; Tsavaris N; Andreadis C; Psychogios J; Poulakaki N
Anticancer Res; 2006; 26(1B):549-52. PubMed ID: 16739318
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer.
Park IH; Ro J; Lee KS; Kim SN; Yun YH; Nam BH
Invest New Drugs; 2010 Oct; 28(5):659-69. PubMed ID: 19575146
[TBL] [Abstract][Full Text] [Related]
13. Introduction. Single-agent or combination chemotherapy in metastatic breast cancer.
Seidman A
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):9-14. PubMed ID: 14768399
[No Abstract] [Full Text] [Related]
14. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study.
Donadio M; Ardine M; Berruti A; Ritorto G; Fea E; Mistrangelo M; Coccorullo Z; Bergnolo P; Comandone A; Bertetto O
Cancer Chemother Pharmacol; 2003 Aug; 52(2):147-52. PubMed ID: 12764672
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
Medioni J; Huchon C; Le Frere-Belda MA; Hofmann H; Bats AS; Eme D; Andrieu JM; Oudard S; Lecuru F; Levy E
Drugs R D; 2011; 11(2):147-57. PubMed ID: 21679005
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma.
Chen JH; Chang PY; Yao NS
Hematol Oncol Stem Cell Ther; 2009; 2(2):371-2. PubMed ID: 20118065
[No Abstract] [Full Text] [Related]
17. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Nicolaides C; Dimopoulos MA; Samantas E; Bafaloukos D; Kalofonos C; Fountzilas G; Razi E; Kosmidis P; Pavlidis N
Ann Oncol; 2000 Jul; 11(7):873-5. PubMed ID: 10997817
[TBL] [Abstract][Full Text] [Related]
18. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).
Gómez HL; Neciosup S; Tosello C; Mano M; Bines J; Ismael G; Santi PX; Pinczowski H; Nerón Y; Fanelli M; Fein L; Sampaio C; Lerzo G; Capó A; Zarba JJ; Blajman C; Varela MS; Martínez-Mesa J; Werutsky G; Barrios CH
Clin Breast Cancer; 2016 Feb; 16(1):38-44. PubMed ID: 26642810
[TBL] [Abstract][Full Text] [Related]
19. Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer.
Dinota A; Bilancia D; Romano R; Manzione L
Breast Cancer Res Treat; 2005 Jan; 89(1):1-3. PubMed ID: 15666190
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for patients with pretreated metastatic breast cancer.
Heinemann V
Lancet Oncol; 2007 Mar; 8(3):187-9. PubMed ID: 17329187
[No Abstract] [Full Text] [Related]
[Next] [New Search]